Progyny (PGNY) Tops Q4 EPS by 1c

Progyny (NASDAQ: PGNY) reported Q4 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $100.3 million versus the consensus estimate of $97.73 million.

GUIDANCE:

Progyny sees Q1 2021 revenue of $520-540 million, versus the consensus of $537.7 million.

For earnings history and earnings-related data on Progyny (PGNY) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
• The First Of Long Island (FLIC) Misses Q1 EPS by 3c